Perspectives on biotherapeutics, regulatory trends, industry–academia collaboration, and biopharma excellence from the Biovigyaana team.
Biotherapeutics represent a paradigm shift in modern medicine. From monoclonal antibodies to cell and gene therapies, we explore what biopharma companies need to succeed in this complex landscape.
Read Article
Biotherapeutics represent a paradigm shift in modern medicine. From monoclonal antibodies to cell and gene therapies, we explore what biopharma companies need to succeed in this complex landscape.
Good Manufacturing Practice compliance is the foundation of safe biopharmaceutical production. This article examines the key elements of a robust GMP quality system for biologics.
The boundary between academic research and industrial application is increasingly blurred. Effective partnerships between universities and industry can accelerate innovation, build talent, and create lasting ecosystems.
India is emerging as a significant player in the global biopharmaceuticals market. Understanding the CDSCO regulatory landscape and the biosimilars framework is essential for companies operating in or entering the Indian market.
Have a question about a topic covered in our articles, or want to discuss how these insights apply to your organisation? Reach out directly.
Contact Our TeamOur articles cover the key areas at the intersection of biopharma science, regulation, and industry practice.